Ozagrel sodium structure
|
Common Name | Ozagrel sodium | ||
---|---|---|---|---|
CAS Number | 189224-26-8 | Molecular Weight | 250.228 | |
Density | N/A | Boiling Point | 468ºC at 760 mmHg | |
Molecular Formula | C13H11N2NaO2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 236.8ºC |
Use of Ozagrel sodiumOzagrel Sodium, also known as KCT-0809 and Cataclot, is a thromboxane A2 synthase inhibitor used to treat cerebrovascular diseases. |
Name | sodium,(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate |
---|---|
Synonym | More Synonyms |
Boiling Point | 468ºC at 760 mmHg |
---|---|
Molecular Formula | C13H11N2NaO2 |
Molecular Weight | 250.228 |
Flash Point | 236.8ºC |
Exact Mass | 250.071823 |
PSA | 57.95000 |
LogP | 0.69450 |
Storage condition | -20℃ |
XanbonS |
OKY-046 sodium |
sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]prop-2-enoate |
Kadenin |
Sodium Ozagrel |
2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, sodium salt, (2E)- (1:1) |
Xanbon |
Sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylate |
Cataclot |
Ozagrel Sodium |
Athrombone |